您的购物车当前为空
RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).

RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively).
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,330 | 35日内发货 | |
| 5 mg | ¥ 8,520 | 35日内发货 | |
| 10 mg | ¥ 14,300 | 35日内发货 |
RF9 相关产品
| 产品描述 | RF9 is an effective and selective antagonist of the Neuropeptide FF receptor (Kis: 58±5 and 75±9 nM for hNPFF1R and hNPFF2R, respectively). |
| 靶点活性 | NPFF1R (human):58±5 nM (Ki), NPFF2R (human):75±9 nM(Ki) |
| 体内活性 | RF9 (10 μg) infused alone does not result in a significant alteration of MAP or heart rate. When NPFF is applied in conjunction with RF9, MAP, and heart rate increases evoked by NPFF are significantly blocked. It is worthy to note that RF9 (30 nmol) significantly reduces the hypothermia induced by morphine (5 nmol) [1][2]. |
| 分子量 | 482.62 |
| 分子式 | C26H38N6O3 |
| CAS No. | 876310-60-0 |
| 密度 | 1.42 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 150 mg/mL (310.8 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (6.84 mM), Sonication is recommeded. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容